£0.06
4.55%
London, Sep 25, 04:28 pm BST. Closed.
ISIN
GB00BYWL4Y04
Symbol
RENX

Renalytix AI plc Stock price

£0.06
+0.02 43.02% 1M
+0.04 179.55% 6M
+0.00 4.24% YTD
-0.04 38.50% 1Y
-0.76 92.55% 3Y
-7.04 99.13% 5Y
-1.14 94.88% 10Y
-1.14 94.88% 20Y
London, Closing price Fri, Sep 25 2026
+0.00 0.00%
ISIN
GB00BYWL4Y04
Symbol
RENX

Is Renalytix AI plc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.

Key metrics

Basic
Market capitalization
£37.1m
Enterprise Value
£40.6m
Net debt
-
Cash
-
Shares outstanding
-
Valuation (TTM | estimate)
P/E
negative
P/S
14.7 | 2.5
EV/Sales
16.1 | 2.8
EV/FCF
negative
P/B
negative
Financial Health
Equity Ratio
-114.8%
Return on Equity
291.4%
ROCE
-1,291.4%
ROIC
-
Debt/Equity
-
Financials (TTM | estimate)
Revenue
£2.5m | £14.4m
EBITDA
£-12.7m
EBIT
£-12.7m
Net Income
£-15.0m
Free Cash Flow
£-9.9m
Growth (TTM | estimate)
Revenue
41.3% | 533.0%
EBITDA
42.4%
EBIT
44.7%
Net Income
42.8%
Free Cash Flow
43.1%
Margin
Gross
44.9%
EBITDA
-501.6%
EBIT
-500.8%
Net
-593.9%
Free Cash Flow
-393.2%
More
EPS
£0.0
FCF per Share
£0.0
Short interest
6,262.0%
Employees
102
Rev per Employee
£20.0k

Renalytix AI plc Stock Analysis

Unlock Scores for Free

Analyst Opinions

5 Analysts have issued a Renalytix AI plc forecast:

4x Buy
80%
1x Hold
20%

Analyst Opinions

5 Analysts have issued a Renalytix AI plc forecast:

Buy
80%
Hold
20%

Financial data from Renalytix AI plc

Dec '25
+/-
%
2.53 2.53
41% 41%
100%
- Direct Costs 1.39 1.39
1% 1%
55%
1.13 1.13
197% 197%
45%
- Selling and Administrative Expenses 14 14
10% 10%
545%
- Research and Development Expense - -
-
-
-13 -13
42% 42%
-501%
- Depreciation and Amortization -0.02 -0.02
102% 102%
-1%
EBIT (Operating Income) EBIT -13 -13
45% 45%
-500%
Net Profit -15 -15
43% 43%
-593%

In millions GBP.

Don't miss a Thing! We will send you all news about Renalytix AI plc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Renalytix AI Plc manufactures medical devices and equipment. It offers artificial intelligence for kidney disease. The company was founded by James McCullough on March 15, 2018 and is headquartered in Penarth, the United Kingdom.

Head office United Kingdom
CEO James McCullough
Employees 102
Founded 2018
Website renalytix.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today